Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure
Top Cited Papers
Open Access
- 1 January 2004
- journal article
- review article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (1) , 256-263
- https://doi.org/10.2337/diacare.27.1.256
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary EdemaMayo Clinic Proceedings, 2003
- Pioglitazone, a Peroxisome Proliferator–Activated Receptor-γ Agonist, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial InfarctionCirculation, 2002
- Peripheral edemaThe American Journal of Medicine, 2002
- Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic PatientsJournal of Clinical Endocrinology & Metabolism, 2002
- Metabolic and Additional Vascular Effects of ThiazolidinedionesDrugs, 2002
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology, 2001
- In Vivo Myocardial Protection From Ischemia/Reperfusion Injury by the Peroxisome Proliferator–Activated Receptor-γ Agonist RosiglitazoneCirculation, 2001
- Impact of Diabetes on Cardiac Structure and FunctionCirculation, 2000
- Pulmonary Edema Associated With Troglitazone TherapyArchives of internal medicine (1960), 1999
- Acute Myocardial Infarction in Diabetes MellitusCirculation, 1998